TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

GRAIL, LLC (GRAL)

Healthcare Diagnostics & Research
70.30 $
+2.5% vs. previous close
Closing price · As of: 3. Aug 2026

GRAIL, LLC (GRAL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 2,922 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet GRAL
Tick rows to compare them in a chart (up to 4) 2018 2019 2020 2021 2022 2023 2024 2025
687 636 706 9,738 5,602 4,557 2,983 2,922
649 558 596 243 296 156 820 954
95 143 170 221 242 97 214 250
641 544 583 221 242 97 763 904
6.9 19 22 25 18
-0.6 20 22 19 16
6,198 1,497 889 0.0
3,074 2,936 2,687 2,017 1,851
86 85 144 307 956 911 480 344
74 45 84 98 135 164 77 80
1.7 5.4 5.4 14 13 15 13 12
13 6.1 25 18 17 20 4.8 2.1
600 551 562 9,431 4,646 3,646 2,503 2,578
-1,061 -1,306 -1,618 -912 -6,311 -7,776 -9,803 -10,212
114 123 124 31 31 31 32 37

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?